Internal Medicine, Rheumatology · Van Nuys, CA
NPI
1912020785
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
15243 Vanowen St Ste 306
Van Nuys, CA, 91405
Phone (818) 781-0232
Groups this clinician bills Medicare through
Medicare paid, 2024
$898K
60,895 services
Medicare patients, 2024
227
Average age 75
Drug cost, 2024
$2.5M
1,850 prescriptions
Company payments, 2024
$104
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raz Khavari was code J3111 (injection, romosozumab-aqqg, 1 mg), 14,314 times for 20 patients. In total Raz Khavari billed 60,895 services in 123 codes, and Medicare paid $898K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-01-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 14,314 | 20 | $8.59 | $123K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,508 | 16 | $33.35 | $150K |
| 86235 Immunoassay | Office | 3,478 | 185 | $17.57 | $61K |
| J0897 Injection, denosumab, 1 mg | Office | 2,147 | 54 | $19.55 | $42K |
| 99214 Office E&M - Established | Office | 1,033 | 211 | $99.16 | $102K |
| 36415 Venipuncture Blood Collection | Office | 1,008 | 221 | $8.65 | $8,719 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 927 | 128 | $0.77 | $715 |
| 82784 Immunoassay | Office | 887 | 186 | $9.11 | $8,083 |
| 85651 Clinical Chemistry | Office | 775 | 211 | $4.20 | $3,252 |
| 86140 Clinical Chemistry | Office | 775 | 211 | $5.09 | $3,943 |
| 85025 Blood Count | Office | 773 | 210 | $7.62 | $5,888 |
| 80053 Clinical Chemistry | Office | 771 | 210 | $10.34 | $7,976 |
| 83520 Immunoassay | Office | 694 | 184 | $16.92 | $12K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 438 | 14 | $23.50 | $10K |
| 84100 Clinical Chemistry | Office | 432 | 201 | $4.65 | $2,009 |
By year: 2022 $565K for 33,319 services; 2023 $579K for 39,750 services; 2024 $898K for 60,895 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 3,478 | 185 | $17.57 | $61K |
| 36415 Venipuncture Blood Collection | 1,008 | 221 | $8.65 | $8,719 |
| 82784 Immunoassay | 887 | 186 | $9.11 | $8,083 |
| 86140 Clinical Chemistry | 775 | 211 | $5.09 | $3,943 |
| 85651 Clinical Chemistry | 775 | 211 | $4.20 | $3,252 |
| 85025 Blood Count | 773 | 210 | $7.62 | $5,888 |
| 80053 Clinical Chemistry | 771 | 210 | $10.34 | $7,976 |
| 83520 Immunoassay | 694 | 184 | $16.92 | $12K |
| 84100 Clinical Chemistry | 432 | 201 | $4.65 | $2,009 |
| 83735 Clinical Chemistry | 431 | 198 | $6.57 | $2,832 |
Medicare prescription drug claims, 2024
In 2024, the drug Raz Khavari prescribed most often to Medicare patients was Gabapentin, with 143 prescriptions and refills. In total Raz Khavari wrote 1,850 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 143 | 197 | 28 | $1,599 |
| Orencia Abatacept/Maltose | 112 | 112 | 13 | $532K |
| Tramadol Hcl Generic | 91 | 91 | 22 | $353 |
| Methotrexate Methotrexate Sodium | 75 | 108 | 13 | $1,911 |
| Prednisone Generic | 68 | 70 | 17 | $366 |
| Cyclobenzaprine Hcl Generic | 64 | 74 | 24 | $902 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 63 | 63 | Under 11 | $1,402 |
| Prolia Denosumab | 61 | 366 | 37 | $98K |
| Colchicine Generic | 61 | 75 | 24 | $2,510 |
| Tymlos Abaloparatide | 60 | 64 | 11 | $172K |
| Omeprazole Generic | 55 | 79 | 13 | $282 |
| Diclofenac Sodium Generic | 53 | 63 | 28 | $2,147 |
| Pregabalin Generic | 45 | 53 | Under 11 | $850 |
| Duloxetine Hcl Generic | 45 | 105 | 13 | $984 |
| Evenity (2 Syringes) Romosozumab-Aqqg | 45 | 45 | Under 11 | $108K |
Brand drugs: - claims; generic drugs: 1,287 claims; opioid claims: 159.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Raz Khavari $104 ($104 in general payments such as food, travel and fees) from 1 company. The largest payer was Regeneron Healthcare Solutions, Inc. with $104.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $104 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.